Skip to main content
SpringerLink
Log in

Intraocular Tumours

  • Chapter
  • First Online:
Lee's Ophthalmic Histopathology

  • 1803 Accesses

Abstract

The most common primary intraocular tumours are malignant melanomas of the uveal tract. The majority of these arise in the choroid with the remainder occurring in the ciliary body and iris. The macroscopic and microscopic features are detailed, as are the pathological appearances associated with poor prognosis. Similarly since many melanomas receive some form of treatment prior to enucleation changes associated with irradiation and local resection should be appreciated. In children the most common primary intraocular tumour is retinoblastoma which is inherited in a small proportion of cases. This causes leucocoria in children which has an important differential diagnosis. Enucleation for metastatic tumours is uncommon except when the primary site is unknown. Lymphoma occasionally occur in the uveal tract and diffuse large cell B cell lymphoma may involve the central nervous system and the retina sometimes in association with human immunodeficiency virus (HIV). Vascular tumours of the retina and choroid may be associated with malformations in the central nervous system (CNS) and skin (von Hippel-Lindau and Sturge-Weber syndrome respectively). Tumours of the epithelium of the ciliary processes and the pigment epithelium of retina are rare as are the tumours derived from the glial cells (astrocytes) of the retina.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Khan S, Finger PT, Yu GP, Razzaq L, Jager MJ, de Keizer RJ, et al. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol. 2012;130:57–64.

    PubMed  Google Scholar 

  2. Teichmann KD, Karcioglu ZA. Melanocytoma of the iris with rapidly developing secondary glaucoma. Surv Ophthalmol. 1995;40:136–44.

    CAS  PubMed  Google Scholar 

  3. Jakobiec FA, Silbert G. Are most iris “melanomas” really naevi? Arch Ophthalmol. 1981;99:2117–32.

    CAS  PubMed  Google Scholar 

  4. Harbour JW, Augsburger JJ, Eagle RC. Initial management and follow-up on melanocytic iris tumours. Ophthalmology. 1995;102:1987–93.

    CAS  PubMed  Google Scholar 

  5. Shields MB. Progressive essential iris atrophy, Chandler’s syndrome and the iris naevus (Cogan Reese) syndrome: a spectrum of disease. Surv Ophthalmol. 1979;24:3–20.

    CAS  PubMed  Google Scholar 

  6. Ozdemir Y, Onder F, Cosar CB, Usbutun A, Kural G. Clinical and histopathologic findings of iris naevus (Cogan Reese) syndrome. Acta Ophthalmol Scand. 1999;77:234–7.

    CAS  PubMed  Google Scholar 

  7. Frangieh GT, El Baba F, Traboulsi EI, Green WR. Melanocytoma of the ciliary body. Surv Ophthalmol. 1985;29:328–34.

    CAS  PubMed  Google Scholar 

  8. Reidy JJ, Apple DJ, Steinmetz RL, Craythorn JM, Loftfield K, Gieser SC, et al. Melanocytoma: nomenclature, pathogenesis, natural history and treatment. Surv Ophthalmol. 1985;29:319–25.

    CAS  PubMed  Google Scholar 

  9. Biswas J, D’Souza C, Shanmugan MP. Diffuse melanocytic lesion of the iris as a presenting feature of ciliary body melanocytoma: report of a case and review of the literature. Surv Ophthalmol. 1998;42:378–82.

    CAS  PubMed  Google Scholar 

  10. Lo Russo FJ, Boniuk M, Font RL. Melanocytoma (magnocellular naevus) of the ciliary body: report of 10 cases and review of the literature. Ophthalmology. 2000;107:795–800.

    CAS  Google Scholar 

  11. El-Harazi SM, Kellaway J, Font RL. Melanocytoma of the ciliary body diagnosed by fine-needle aspiration biopsy. Diagn Cytopathol. 2000;22:394–7.

    CAS  PubMed  Google Scholar 

  12. Shields JA, Shields CL, Eagle Jr RC. Melanocytoma (hyperpigmented magnocellular nevus) of the uveal tract: the 34th G. Victor Simpson lecture. Retina. 2007;27(6):730–9.

    PubMed  Google Scholar 

  13. Rummelt V, Naumann GOH, Folberg R, Weingeist TA. Surgical management of melanocytoma of the ciliary body with extrascleral extension. Am J Ophthalmol. 1994;117:169–76.

    CAS  PubMed  Google Scholar 

  14. Fineman MS, Eagle RC, Shields JA, Shields CL, De Potter P. Melanocytomalytic glaucoma in eyes with necrotic iris melanocytoma. Ophthalmology. 1998;105:492–6.

    CAS  PubMed  Google Scholar 

  15. Gonder JR, Augsburger JJ, McCarthy EF, Shields JA. Visual loss associated with choroidal naevi. Ophthalmology. 1982;89:950–2.

    CAS  PubMed  Google Scholar 

  16. Margo CE, Pavan PR, Gendelman D, Gragoudas E. Bilateral melanocytic uveal tumours associated with systemic non-ocular malignancy. Malignant melanomas or benign paraneoplastic syndrome. Retina. 1987;7:137–41.

    CAS  PubMed  Google Scholar 

  17. Gass JDM, Gieser RG, Wilkinson CP, Beahm DE, Pautler SE. Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol. 1990;105:372–9.

    Google Scholar 

  18. Seregard S, af Trampe E, Mansson-Brahme E, Kock E, Bergenmar M, Ringborg U. Prevalence of primary acquired melanosis and naevi of the conjunctiva and uvea in the dysplastic naevus syndrome. Ophthalmology. 1995;102:136–44.

    Google Scholar 

  19. Hansson J, Bergenmar M, Hofer PA, Lundell G, Månsson-Brahme E, Ringborg U, Synnerstad I, Bratel AT, Wennberg AM, Rosdahl I. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. J Clin Oncol. 2007;25(19):2819–24.

    PubMed  Google Scholar 

  20. Borden AF, Wray ML, Belfort R, McLean IW, Burnier M. Choroidal malignant melanoma in association with oculodermal melanocytosis in a black patient. Br J Ophthalmol. 1995;79:191–2.

    Google Scholar 

  21. Infante de German-Ribon R, Singh AD, Arevalo JF, Driebe W, Eskin T. Choroidal melanoma with oculodermal melanocytosis in Hispanic patients. Am J Ophthalmol. 1999;128:251–3.

    CAS  PubMed  Google Scholar 

  22. Brown GC, Shields JA. Tumours of the optic nerve head. Surv Ophthalmol. 1985;29:239–64.

    CAS  PubMed  Google Scholar 

  23. Shields JA, Dermirci H, Mashayekhi A, Eagle Jr RC, Shields CL. Melanocytoma of the optic disk: a review. Surv Ophthal. 2006;51(2):93–104.

    Google Scholar 

  24. Meyer D, Ge J, Blinder KJ, Sinard J, Xu S. Malignant transformation of an optic disc melanocytoma. Am J Ophthalmol. 1999;127:710–4.

    CAS  PubMed  Google Scholar 

  25. Hassenstein A, Bialasiewicz AA, von Domarus D, Schafer H, Richard D. Tapioca melanoma of the iris: immunology and report on two cases. Graefes Arch Clin Exp Ophthalmol. 1999;237:424–8.

    CAS  PubMed  Google Scholar 

  26. Conway RM, Chew T, Golchet P, Desai K, Lin S, O’Brien J. Ultrasound biomicroscopy: role in diagnosis and management in 130 consecutive patients evaluated for anterior segment tumours. Br J Ophthalmol. 2005;89:950–5.

    CAS  PubMed  Google Scholar 

  27. Grossniklaus HE. Fine needle aspiration biopsy of the iris. Arch Ophthalmol. 1993;110:969–76.

    Google Scholar 

  28. Shields CS, Manquez ME, Ehya H, Mashayekhi A, Danzig CJ, Shields JA. Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases: technique and complications. Ophthalmology. 2006;113:2080–6.

    PubMed  Google Scholar 

  29. Char DH, Crawford JB, Kroll S. Iris melanomas. Diagnostic problems. Ophthalmology. 1996;103:251–5.

    CAS  PubMed  Google Scholar 

  30. Shields CL, Naseripour M, Shields JA, Freire J, Cater J. Custom designed plaque radiotherapy for non-resectable iris melanoma in 38 pts: tumour control and ocular complications. Am J Ophthalmol. 2003;135:648–56.

    PubMed  Google Scholar 

  31. Rundle P, Singh AD, Rennie I. Proton beam therapy for iris melanoma: a review of 15 cases. Eye. 2007;21:79–82.

    CAS  PubMed  Google Scholar 

  32. Henderson E, Margo CE. Iris melanoma. Arch Path Lab Med. 2008;132:268–72.

    PubMed  Google Scholar 

  33. Damato B. Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye (Lond). 2012;26:1157–72.

    CAS  Google Scholar 

  34. Burnier Jr MN, McLean IW, Gamel JW. Immunohistochemical evaluation of uveal melanocytic tumors: expression of HMB-45- S-100 protein, and neuronspecific enolase. Cancer. 1991;68:809–14.

    PubMed  Google Scholar 

  35. Iwamoto S, Burrows RC, Grossniklaus HE, Orcutt J, Kalina RE, Boehm M, et al. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol. 2002;12:1625–9.

    Google Scholar 

  36. Chowers I, Amer R, Pe’er J. The correlation among different immunostaining evaluation methods for the assessment of proliferative activity in uveal melanoma. Curr Eye Res. 2002;25(6):369–72.

    PubMed  Google Scholar 

  37. Finger PT. The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med. 2009;133:1197–8.

    PubMed  Google Scholar 

  38. Bechrakis N, Lee WR. Dedifferentiation potential of iris melanomas. Fortschtr Ophthalmol. 1991;88:651–6.

    CAS  Google Scholar 

  39. Grossniklaus HE, Brown RH, Stulting RD, Blasberg RD. Iris melanoma seeding through a trabeculectomy site. Arch Ophthalmol. 1990;108:1287–90.

    CAS  PubMed  Google Scholar 

  40. Brown D, Boniuk M, Font RL. Diffuse malignant melanoma of iris with metastases. Surv Ophthalmol. 1990;34:357–64.

    CAS  PubMed  Google Scholar 

  41. Shields CL, Shields JA, Materin M, Gershenbaum E, Singh AD, Smith A. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology. 2001;108:172–8.

    CAS  PubMed  Google Scholar 

  42. Demirci H, Shields CL, Shields JA, Eagle Jr RC, Honavar SG. Diffuse iris melanoma: a report of 25 cases. Ophthalmology. 2002;109:1553–60.

    PubMed  Google Scholar 

  43. Dunn WJ, Lambert HM, Kincaid MC, Dieckert JP, Shore JW. Primary malignant melanoma with early vitreous seeding. Retina. 1988;8:188–92.

    CAS  PubMed  Google Scholar 

  44. McMenamin PG, Lee WR. Ultrastructural pathology of melanomalytic glaucoma. Br J Ophthalmol. 1986;70:895–906.

    CAS  PubMed  Google Scholar 

  45. Latina M, Flotte T, Crean E, Sherwood E, Granstein RD. Immunohistochemical staining of the human anterior segment. Evidence that resident cells play a role in immunologic response. Arch Ophthalmol. 1988;106:95–9.

    CAS  PubMed  Google Scholar 

  46. Rosenbaum PS, Boniuk M, Font RL. Diffuse melanoma in a 5 year old child. Am J Ophthalmol. 1988;106:601–6.

    CAS  PubMed  Google Scholar 

  47. Shields CL, Kaliki S, Shah SU, Luo W, Furuta M, Shields JA. Iris melanoma: features and prognosis in 317 children and adults. J AAPOS. 2012;16:10–6.

    PubMed  Google Scholar 

  48. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiological aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239–51.

    CAS  PubMed  Google Scholar 

  49. Raoof N, Rennie IG, Salvi SM, Sisley K, Caine A, Mudhar HS. What is the significance of vortex vein invasion in uveal melanoma. Eye. 2009;23:1661–7.

    CAS  PubMed  Google Scholar 

  50. Font RL, Spaulding AG, Zimmerman LE. Diffuse malignant melanoma of the uveal tract. Trans Am Acad Ophthalmol Otolaryngol. 1968;72:877–94.

    CAS  PubMed  Google Scholar 

  51. Blumenthal EZ, Pe’er J. Multifocal choroidal melanoma: at least three melanomas in one eye. Arch Ophthalmol. 1999;117:255–8.

    CAS  PubMed  Google Scholar 

  52. Lindegaard J. Primary and secondary tumours of the optic nerve, with emphasis on invasion of uveal malignant melanoma. Acta Ophthalmol Scand. 2007;85(3):347–8.

    PubMed  Google Scholar 

  53. De Potter P, Shields CL, Eagle RC, Shields JA, Lipkowitz JL. Malignant melanoma of the optic nerve. Arch Ophthalmol. 1996;114:608–12.

    PubMed  Google Scholar 

  54. Collaborative ocular melanoma study group (COMS). Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study. Am J Ophthalmol. 1998;125:745–66.

    Google Scholar 

  55. Collaborative ocular melanoma study group (COMS). The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. II initial mortality findings. Am J Ophthalmol. 1998;125:779–96.

    Google Scholar 

  56. Khahlil MK. Balloon cell malignant melanoma of the choroid. Br J Ophthalmol. 1983;67:579–84.

    Google Scholar 

  57. Grossniklaus HE, Albert AM, Green WR, Conway BP, Hofland KR. Clear cell differentiation in choroidal melanoma. Arch Ophthalmol. 1997;115:894–8.

    CAS  PubMed  Google Scholar 

  58. Shields CL, Shields JA, Cook GR, von Fricken MA, Augsburger JJ. Differentiation of adenoma of the iris pigment epithelium from iris cyst and melanoma. Am J Ophthalmol. 1985;100:678–81.

    CAS  PubMed  Google Scholar 

  59. Shields JA, Augsburger JJ, Donoso LA, Bernardino VB, Portenar M. Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol. 1995;100:666–8.

    Google Scholar 

  60. Coupland SE, Sidiki S, Clark BJ, McClaren K, Kyle P, Lee WR. Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation. Arch Ophthalmol. 1996;114:751–6.

    CAS  PubMed  Google Scholar 

  61. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115(10):1778–85.

    PubMed  Google Scholar 

  62. Jensen OA. Malignant melanomas of the human uvea. 25-year follow-up of cases in Denmark 1943–1952. Acta Ophthalmol. 1982;60:161–82.

    CAS  Google Scholar 

  63. McLean IW, Foster WD, Zimmerman LE. Uveal melanoma: location, size, cell type and enucleation as risk factors in metastasis. Hum Pathol. 1982;13:123–32.

    CAS  PubMed  Google Scholar 

  64. Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand. 2004;82:517–25.

    PubMed  Google Scholar 

  65. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123:1639–43.

    PubMed  Google Scholar 

  66. Collaborative ocular melanoma study group (COMS). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–93.

    Google Scholar 

  67. Damato B, Coupland SE. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond). 2009;23(12):2152–62.

    CAS  Google Scholar 

  68. Sakamoto T, Sakamoto M, Yoshikawa H, Hata Y, Ishibashi T, Ohnishi Y, Inomata H. Histologic findings and prognosis of uveal melanoma in Japanese patients. Am J Ophthalmol. 1996;121:276–83.

    CAS  PubMed  Google Scholar 

  69. Folberg R, Mehaffy M, Gardner LM, Meyer M, Rummelt V, Pe’er J. The microcirculation of choroidal and ciliary body melanomas. Eye. 1997;11:227–38.

    PubMed  Google Scholar 

  70. McLean IW, Keefe KS, Burnier MN. Uveal melanoma comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type and tumour size. Ophthalmology. 1997;104:777–80.

    CAS  PubMed  Google Scholar 

  71. Hoglund M, Gisselsson D, Hansen GB, White VA, Säll T, Mitelman F, et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer. 2004;108(1):57–65.

    PubMed  Google Scholar 

  72. Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30:285–95.

    PubMed  Google Scholar 

  73. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222–5.

    CAS  PubMed  Google Scholar 

  74. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 1998;83:354–9.

    CAS  PubMed  Google Scholar 

  75. Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003;44(3):1008–11.

    PubMed  Google Scholar 

  76. Kilic E, van Gils W, Lodder E, Beverloo HB, van Til ME, Mooy CM, et al. Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci. 2006;47(9):3703–7.

    PubMed  Google Scholar 

  77. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114:1925–31.

    PubMed  Google Scholar 

  78. Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, et al. Abnormalities of chromosome 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 1997;19(1):22–8.

    CAS  PubMed  Google Scholar 

  79. Patel KA, Edmondson ND, Talbot F, Parsons MA, Rennie IG, Sisley K, et al. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol. 2001;85:1440–4.

    CAS  PubMed  Google Scholar 

  80. Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation dependent probe amplification. Clin Cancer Res. 2010;16(24):6083–92.

    CAS  PubMed  Google Scholar 

  81. van den Bosch T, van Beek JG, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, de Klein A, Kiliç E. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Invest Ophthalmol Vis Sci. 2012;53(6):2668–74.

    PubMed  Google Scholar 

  82. Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005;46(7):2253–7.

    PubMed  Google Scholar 

  83. Rennie IG. Uveal melanoma: the past, the present and the future. Eye. 1997;11:255–64.

    PubMed  Google Scholar 

  84. Coupland SE. Molecular pathology of lymphoma. Eye (Lond). 2013;27(2):180–9.

    CAS  Google Scholar 

  85. Trolet J, Hupe P, Huon I, Lebigot C, Decraene C, Delattre O, et al. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases invest. Ophthalmol Vis Sci. 2009;50(6):2572–80.

    Google Scholar 

  86. Laurent C, Valet F, Planque N, Silveri L, Maacha S, Anezo O, et al. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res. 2010;71(3):666–74.

    PubMed  Google Scholar 

  87. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410–3.

    CAS  PubMed  Google Scholar 

  88. Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet. 2011;48(12):856–9.

    CAS  PubMed  Google Scholar 

  89. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43(10):1022–5.

    CAS  PubMed  Google Scholar 

  90. Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011;43(10):1018–21.

    CAS  PubMed  Google Scholar 

  91. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012;7(4):e35295.

    CAS  PubMed  Google Scholar 

  92. Carbone M, Korb Ferris L, Baumann F, Napolitano A, Lum CA, Flores EG, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10(1):179.

    CAS  PubMed  Google Scholar 

  93. Onken MD, Worley LA, Tuscan MD, Harbour JW. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn. 2010;12(4):461–8.

    CAS  PubMed  Google Scholar 

  94. Al-Jamal RT, Kivelä T. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors. Curr Eye Res. 2006;31(1):57–67.

    CAS  PubMed  Google Scholar 

  95. Mooy CM, de Jong PTVM. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41:215–28.

    CAS  PubMed  Google Scholar 

  96. Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns and PC-10 in posterior uveal melanomas. Ophthalmology. 1998;105:485–91.

    CAS  PubMed  Google Scholar 

  97. Bakalian S, Marshall JC, Faingold D, Logan P, Antecka E, Burnier Jr MN. Expression of nm23-H1 in uveal melanoma. Melanoma Res. 2007;17(5):284–90.

    CAS  PubMed  Google Scholar 

  98. Coleman K, Baak JPH, Dorman A, Mullaney J, Curran B, Tiernan D, et al. Deoxyribonucleic acid ploidy studies in choroidal melanomas. Am J Ophthalmol. 1993;115:376–83.

    CAS  PubMed  Google Scholar 

  99. Elavathil LJ, Le Riche J, Rootman J, Gallagher RP, Phillips D. Prognostic value of DNA ploidy as assessed by flow cytometry in uveal melanoma. Can J Ophthalmol. 1995;30:360–5.

    CAS  PubMed  Google Scholar 

  100. Richardson RPS, Lawry L, Rees RC, Rennie IG. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry. Eye. 1997;11:629–34.

    PubMed  Google Scholar 

  101. Lawry J, Smith MO, Parsons MA, Rennie IG. Simultaneous cell cycle and phenotypic analysis of primary melanoma by flow cytometry. Eye. 1998;12:431–9.

    PubMed  Google Scholar 

  102. Sheidow TG, Hooper PL, Crukley C, Young J, Heathcote JG. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastases. Br J Ophthalmol. 2000;84:750–6.

    CAS  PubMed  Google Scholar 

  103. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol. 1978;62:420–5.

    CAS  PubMed  Google Scholar 

  104. Manschot WA, van Peperzeel HA. Choroidal melanoma. Enucleation or observation? A new approach. Arch Ophthalmol. 1980;98:71–7.

    CAS  PubMed  Google Scholar 

  105. Zimmerman LE, McLean IW, Foster WD. The Manschot-van Peperzeel concept of the growth and metastasis of uveal melanomas. Doc Ophthalmol. 1980;50:101–21.

    CAS  PubMed  Google Scholar 

  106. Gunduz K, Shields JA, Shields CL, Eagle RC, Diniz W, Mercado G, Chang W. Transscleral choroidal biopsy in the diagnosis of choroidal lymphoma. Surv Ophthalmol. 1999;43:551–5.

    CAS  PubMed  Google Scholar 

  107. Naumann GOH, Rummelt V. Block excision of tumors of the anterior uvea. Report on 68 consecutive patients. Ophthalmology. 1996;103:2017–28.

    CAS  PubMed  Google Scholar 

  108. Shields JA, Shields CL, Shah P, Sivilangham V. Partial lamellar sclerouvectomy for ciliary body and choroidal tumours. Ophthalmology. 1991;98:971–83.

    CAS  PubMed  Google Scholar 

  109. Damato BE, Paul J, Foulds WS. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol. 1996;80:102–8.

    CAS  PubMed  Google Scholar 

  110. Damato BE, Paul J, Foulds WS. Risk factors for metastatic uveal melanoma after trans-scleral local resection. Br J Ophthalmol. 1996;80:109–16.

    CAS  PubMed  Google Scholar 

  111. Damato B, Groenewald C, McGalliard J, Wong D. Endoresection of choroidal melanoma. Br J Ophthalmol. 1998;82:213–8.

    CAS  PubMed  Google Scholar 

  112. Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin. 2006;46:95–107.

    PubMed  Google Scholar 

  113. Schilling H, Bornfeld N, Talies S, Anastassiou G, Schüler A, Horstmann GA. Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife–first experience on 46 cases. Klin Monbl Augenheilkd. 2006;223:513–20.

    CAS  PubMed  Google Scholar 

  114. Logani S, Cho AS, Su LD, Withers HR, McBride WH, Hall MO, et al. Effects of gamma radiation on the OM431 human ocular melanoma cell line. Exp Eye Res. 1995;60:603–5.

    CAS  PubMed  Google Scholar 

  115. Soulières D, Rousseau A, Tardif M, Larochelle M, Tremblay M, Vaillancourt L, et al. The radiosensitivity of uveal melanomas and the cell survival curve. Graefes Arch Clin Exp Ophthalmol. 1995;233:85–9.

    PubMed  Google Scholar 

  116. Quivey JM, Augsburger J, Snelling L, Brady LW. I125 plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control. Cancer. 1996;77:2356–62.

    CAS  PubMed  Google Scholar 

  117. Lee WR. Pseudomelanomas after conservative management of uveal melanoma. Eye. 1987;1:668–75.

    PubMed  Google Scholar 

  118. Shields CL, Shields JA, Karlsson U, Menduke H, Brady LW. Enucleation after plaque radiotherapy for posterior uveal melanoma: histopathologic findings. Ophthalmology. 1990;97:1665–70.

    CAS  PubMed  Google Scholar 

  119. Augsburger JJ, Correa ZM, Freire J, Brady LW. Long term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Ophthalmology. 1998;105:1670–8.

    CAS  PubMed  Google Scholar 

  120. Finger PT, Berson A, Szechter A. Palladium103 radiotherapy for choroidal melanoma. Results of a 7 year study. Ophthalmology. 1999;106:606–13.

    CAS  PubMed  Google Scholar 

  121. Schilling H, Sehu KW, Lee WR. A histologic study (including DNA quantification and ki-67 labelling index) in uveal melanomas after brachytherapy with ruthenium plaques. Invest Ophthalmol Vis Sci. 1997;38:2081–92.

    CAS  PubMed  Google Scholar 

  122. Gragoudas ES, Seddon JM, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, et al. Long term results of proton beam irradiated melanomas. Ophthalmology. 1987;94:349–53.

    CAS  PubMed  Google Scholar 

  123. Castro JR, Char DH, Petti PL, Daftari IK, Quivey JM, Singh RP, et al. 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39:989–96.

    CAS  PubMed  Google Scholar 

  124. Char DH, Kroll SM, Castro J. Ten year follow up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998;125:81–9.

    CAS  PubMed  Google Scholar 

  125. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys. 2005;62:1405–11.

    PubMed  Google Scholar 

  126. Daftari IK, Char DH, Verhey LJ, Castro JR, Petti PL, Meecham WJ. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39:997–1010.

    CAS  PubMed  Google Scholar 

  127. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992;110:1112–8.

    CAS  PubMed  Google Scholar 

  128. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42:215–32.

    CAS  PubMed  Google Scholar 

  129. Collaborative ocular melanoma study group (COMS). The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. III Local complications and observations following enucleation. Am J Ophthalmol. 1998;126:362–72.

    Google Scholar 

  130. Oosterhuis JA, Journee de Korver HG, Keunen JEE. Transpupillary thermotherapy. Results in 50 patients with choroidal melanoma. Arch Ophthalmol. 1998;116:157–62.

    CAS  PubMed  Google Scholar 

  131. Diaz CE, Capone A, Grossniklaus HE. Clinicopathologic findings in recurrent choroidal melanoma after transpupillary thermotherapy. Ophthalmology. 1998;105:1419–24.

    CAS  PubMed  Google Scholar 

  132. Ashton N. Primary tumours of the iris. Br J Ophthalmol. 1964;48:650–68.

    CAS  PubMed  Google Scholar 

  133. Dugmore WN. Eleven year follow-up of a case of leiomyosarcoma. Br J Ophthalmol. 1972;56:366–7.

    CAS  PubMed  Google Scholar 

  134. Sevel D, Tobias B. The value of fluorescein angiography with leiomyoma of the iris. Am J Ophthalmol. 1972;74:475–8.

    CAS  PubMed  Google Scholar 

  135. Eide N, Farstad IN, Røger M. A leiomyoma of the iris documented by immunohistochemistry and electron microscopy. Acta Ophthalmol Scand. 1997;75(4):470–3.

    CAS  PubMed  Google Scholar 

  136. Shields JA, Font RL, Eagle RC, Shields CL, Gass JDM. Melanotic Schwannoma of the choroid. Ophthalmology. 1994;101:843–9.

    CAS  PubMed  Google Scholar 

  137. Foss AJE, Pecorella I, Alexander RA, Hungerford JL, Garner A. Are most intraocular “leiomyomas” really melanocytic lesions? Ophthalmology. 1994;101:919–24.

    CAS  PubMed  Google Scholar 

  138. Biswas J, Kumar SK, Gopal L, Bende MP. Leiomyoma of the ciliary body extending to the anterior chamber: clinicopathologic and ultrasound biomicroscopic correlation. Surv Ophthalmol. 2000;44:336–42.

    CAS  PubMed  Google Scholar 

  139. Naumann GOH, Ruprecht KW. Xanthome der Iris. Ophthalmologica. 1972;164:292–305.

    Google Scholar 

  140. Naumann GOH, Font RL, Zimmerman LE. Electron microscopic verification of primary rhabdomyosarcoma of the iris. Am J Ophthalmol. 1972;74:110–7.

    Google Scholar 

  141. Sukavatcharin S, Cursino S, Li G, Green RL, Lim JI, Rao NA. Xanthogranuloma of the iris simulating melanoma in an adult. Am J Ophthalmol. 2007;143(3):529–31.

    PubMed  Google Scholar 

  142. Li Z-Y, Tso MOM, Sugar J. Leiomyoepithelioma of the iris pigment epithelium. Arch Ophthalmol. 1987;105:819–24.

    CAS  PubMed  Google Scholar 

  143. Shields JA, Bianciotto C, Kligman BE, Shields CL. Vascular tumors of the iris in 45 patients: the 2009 Helen Keller Lecture. Arch Ophthalmol. 2010;128(9):1107–13.

    PubMed  Google Scholar 

  144. Shields CL, Santos C, Diniz W, Gündüz K, Mercado G, Cater JR, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885–93.

    CAS  PubMed  Google Scholar 

  145. Singh AD, Rundle PA, Longstaff S, Jacques R, Rennie IG. Iris pigment epithelial adenoma: resection and repair. Eye (Lond). 2006;20(3):385–6.

    CAS  Google Scholar 

  146. Spraul CW, d’Heurle D, Grossniklaus HE. Adenocarcinoma of the iris pigment epithelium. Arch Ophthalmol. 1996;114:1512–7.

    CAS  PubMed  Google Scholar 

  147. Carruthers JDA, Saunders PPR, McCormick AQ. Nonpigmented congenital iris stromal cyst. Can J Ophthalmol. 1990;25:309–10.

    CAS  PubMed  Google Scholar 

  148. Sneed SR, Vine AK, Arbor A. Spontaneous collapse of a primary iris cyst associated with an iris nevus. Arch Ophthalmol. 1991;109:21–2.

    CAS  PubMed  Google Scholar 

  149. Lois N, Shields CL, Shields JA, Mercado G, De Potter P. Primary iris stromal cysts. A report of 17 cases. Ophthalmology. 1998;105:1317–22.

    CAS  PubMed  Google Scholar 

  150. Lois N, Shields CL, Shields JA, Mercado G. Primary cysts of the iris pigment epithelium. Clinical features and natural course in 234 patients. Ophthalmology. 1998;105:1879–95.

    CAS  PubMed  Google Scholar 

  151. Milman T, Petousis V, McCormick SA, Finger PT. Anterior segment tumor aspiration cutter-assisted biopsy: experience with pathology. Am J Ophthalmol. 2011;152(5):776–83.

    PubMed  Google Scholar 

  152. Rummelt V, Rummelt C, Naumann GOH. Congenital nonpigmented epithelial iris cyst after amniocentesis. Clinicopathologic report on two children. Ophthalmology. 1993;100:776–81.

    CAS  PubMed  Google Scholar 

  153. Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104:1265–76.

    CAS  PubMed  Google Scholar 

  154. Ainsworth JR, Damato BE, Lee WR, Alexander WD. Follicular thyroid carcinoma metastatic to the iris: a solitary lesion treated with iridocyclectomy. Arch Ophthalmol. 1991;110:19–20.

    Google Scholar 

  155. Sach J, Krepelkova J, Kuchynka P. Haemangiosarcoma of the breast metastatic to the ciliary body and the iris. Br J Ophthalmol. 1998;82:709–11.

    CAS  PubMed  Google Scholar 

  156. Capeans C, Santos L, Sanchez-Salorio M, Forteza J. Iris metastases from endometrial carcinoma. Am J Ophthalmol. 1998;125:729–30.

    CAS  PubMed  Google Scholar 

  157. Sarenac TS, Janicijevic-Petrovic MA, Sreckovic SB, Radovanovic MR, Vulovic DD, Janicijevic KM. Prostatic carcinoma bilateral iris metastases. Bosn J Basic Med Sci. 2012;12(2):134–6.

    PubMed  Google Scholar 

  158. Dhakal S, Lema GM, Diloreto Jr DA, Katz AW. Esophageal metastasis to the iris effectively palliated using stereotactic body radiation therapy and adjuvant intravitreal chemotherapy: case report and literature review. Case Rep Oncol. 2012;5(3):639–43.

    PubMed  Google Scholar 

  159. Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB, Chan C-C. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol. 2000;44:518–26.

    CAS  PubMed  Google Scholar 

  160. Mashayekhi A, Shields CL, Shields JA. Iris involvement by lymphoma: a review of 13 cases. Clin Experiment Ophthalmol. 2013;41(1):19–26.

    PubMed  Google Scholar 

  161. Shields JA, Shields CL, Eagle RC, De Potter P. Observations on seven cases of intraocular leiomyoma. The 1993 Byron Demorest Lecture. Arch Ophthalmol. 1994;112:521–8.

    CAS  PubMed  Google Scholar 

  162. Biswas J, Mani B, Shanmugam MP, Patwardhan D, Kumar KS, Badrinath SS. Retinoblastoma in adults: report of three cases and review of the literature. Surv Ophthalmol. 2000;44:409–14.

    CAS  PubMed  Google Scholar 

  163. Kanavi MR, Soheilian M, Peyman GA. Ciliary body leiomyoma with atypical features. Can J Ophthalmol. 2007;42(2):336–7.

    PubMed  Google Scholar 

  164. Shields CL, Shields JA, Varenhorst MP. Transscleral leiomyoma. Ophthalmology. 1991;98:84–7.

    CAS  PubMed  Google Scholar 

  165. Cajaiba MM, Chojniak MM, Cunha IW. Unusual primary ocular neoplasm in a child: leiomyosarcoma of the ciliary body. Pediatr Dev Pathol. 2008;11(6):479–81.

    PubMed  Google Scholar 

  166. Wilson ME, McClatchey SK, Zimmerman LE. Rhabdomyosarcoma of the ciliary body. Ophthalmology. 1990;97:1484–8.

    CAS  PubMed  Google Scholar 

  167. Brown HH, Brodsky MC, Hembree K, Mrak RE. Supraciliary hemangiopericytoma. Ophthalmology. 1991;98:378–82.

    CAS  PubMed  Google Scholar 

  168. Gieser SC, Hufnagel TJ, Jaros PA, MacRae D, Khodadoust AA. Haemangiopericytoma of the ciliary body. Arch Ophthalmol. 1988;106:1269–72.

    CAS  PubMed  Google Scholar 

  169. Smith PA, Damato BE, Ko M-K, Lyness RW. Anterior uveal neurilemmoma – a rare neoplasm simulating malignant melanoma. Br J Ophthalmol. 1987;71:34–40.

    CAS  PubMed  Google Scholar 

  170. Kuchle M, Holbach L, Schlotzer-Schrehardt U, Naumann GOH. Schwannoma of the ciliary body treated by block excision. Br J Ophthalmol. 1994;78:397–400.

    CAS  PubMed  Google Scholar 

  171. Kim IT, Chang SD. Ciliary body schwannoma. Acta Ophthalmol Scand. 1999;77(4):462–6.

    CAS  PubMed  Google Scholar 

  172. Goto H, Mori H, Shirato S, Usui M. Ciliary body schwannoma successfully treated by local resection. Jpn J Ophthalmol. 2006;50(6):543–6.

    PubMed  Google Scholar 

  173. Tagaki UY, Matsuya N. Mesoectodermal leiomyoma of the ciliary body: an ultrastructural study. Arch Ophthalmol. 1985;103:1711.

    Google Scholar 

  174. Ishigooka H, Yamabe H, Kobashi Y, Nagata M. Clinical and pathological status of mesectodermal leiomyoma of the ciliary body. Graefes Arch Clin Exp Ophthalmol. 1989;227:101–5.

    CAS  PubMed  Google Scholar 

  175. White V, Stephenson K, Garner A, Hungerford J. Mesectodermal leiomyoma of the ciliary body: case report. Br J Ophthalmol. 1989;73:12–8.

    CAS  PubMed  Google Scholar 

  176. Yu DY, Cohen SB, Peyman G, Tso MOM. Mesectodermal leiomyoma of the ciliary body: new evidence for neural crest origin. J Paediatr Ophthalmol Strabismus. 1990;27:317–21.

    CAS  Google Scholar 

  177. Campbell RJ, Min KW, Bolling JP. Skeinoid fibres in mesectodermal leiomyoma of the ciliary body. Ultrastruct Pathol. 1997;21:559–67.

    CAS  PubMed  Google Scholar 

  178. Park SW, Kim HJ, Chin HS, Tae KS, Han JY. Mesectodermal leiomyosarcoma of the ciliary body. AJNR Am J Neuroradiol. 2003;24(9):1765–8.

    PubMed  Google Scholar 

  179. Lai CT, Tai MC, Liang CM, Lee HS. Unusual uveal tract tumor: mesectodermal leiomyoma of the ciliary body. Pathol Int. 2004;54:337–42.

    PubMed  Google Scholar 

  180. Odashiro AN, Fernandes BF, Al Kandari A, Gregoire FJ, Burnier MN. Report of two cases of ciliary body mesectodermal leiomyoma – unique expression of neural markers. Ophthalmology. 2007;114:157–61.

    PubMed  Google Scholar 

  181. Koletsa T, Karayannopoulou G, Dereklis D, Vasileiadis I, Papadimitriou CS, Hytiroglou P. Mesectodermal leiomyoma of the ciliary body: report of a case and review of the literature. Pathol Res Pract. 2009;205(2):125–30.

    PubMed  Google Scholar 

  182. Lieb WE, Shields JA, Eagle RC, Kwa D, Shields CL. Cystic adenoma of the pigmented ciliary epithelium: clinical, pathologic and immunohistopathologic findings. Ophthalmology. 1990;97:1489–93.

    CAS  PubMed  Google Scholar 

  183. Assheton DC, Guerin EP, Sheridan CM, Bishop PN, Hiscott PS. Neoplastic transformation of ciliary body epithelium is associated with loss of opticin expression. Br J Ophthalmol. 2007;91(2):230–2.

    PubMed  Google Scholar 

  184. Reardon AJ, Le Goff M, Briggs MD, McLeod D, Sheehan JK, Thornton DJ, et al. Identification in vitreous and molecular cloning of opticin, a novel member family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem. 2000;275:2123–9.

    CAS  PubMed  Google Scholar 

  185. Takanosu M, Boyd TC, Le Goff M, Henry SP, Zhang Y, Bishop PN, et al. Structure, chromosomal location and tissue-specific expression of the mouse opticin gene. Invest Ophthalmol Vis Sci. 2001;42:2202–10.

    CAS  PubMed  Google Scholar 

  186. Bishop PN, Takanosu M, Le Goff M, Mayne R. The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye. 2002;16:454–60.

    CAS  PubMed  Google Scholar 

  187. Ramesh S, Bonshek RE, Bishop PN. Immunolocalisation of opticin in the human eye. Br J Ophthalmol. 2004;88:697–702.

    CAS  PubMed  Google Scholar 

  188. Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclindependent kinases. J Clin Invest. 1997;100:149–57.

    CAS  PubMed  Google Scholar 

  189. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem. 1999;274:18843–6.

    CAS  PubMed  Google Scholar 

  190. Rennie IG, Parsons MA, Palmer CAL. Congenital adenoma of the iris and ciliary body: light and electron microscopic observations. Br J Ophthalmol. 1992;76:563–6.

    CAS  PubMed  Google Scholar 

  191. Grossniklaus HE, Lim JI. Adenoma of the nonpigmented ciliary epithelium. Retina. 1994;14(5):452–6.

    CAS  PubMed  Google Scholar 

  192. Shields JA, Eagle RC, Shields CL, De Potter P. Acquired neoplasms of the nonpigmented ciliary epithelium (adenoma and adenocarcinoma). Ophthalmology. 1996;103:2007–16.

    CAS  PubMed  Google Scholar 

  193. Mansoor S, Qureshi A. Ciliary body adenoma of nonpigmented epithelium. J Clin Pathol. 2004;57(9):997–8.

    CAS  PubMed  Google Scholar 

  194. Chen ZQ, Fang XY. Adenoma of nonpigmented epithelium in ciliary body: literature review and case report. J Zhejiang Univ Sci B. 2007;8(9):612–5.

    PubMed  Google Scholar 

  195. Bae JH, Kwon JE, Yang WI, Lee SC. Adenoma of the nonpigmented ciliary epithelium presenting with recurrent iridocyclitis: unique expression of glial fibrillary acidic protein. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1747–9.

    PubMed  Google Scholar 

  196. Rennie IG, Faulkner MK, Parsons MA. Adenoma of the pigmented ciliary epithelium. Br J Ophthalmol. 1994;78(6):484–5.

    CAS  PubMed  Google Scholar 

  197. Dryja TP, Albert DM, Horns D. Adenocarcinoma arising from the epithelium of the ciliary body. Ophthalmology. 1981;88:1290–2.

    CAS  PubMed  Google Scholar 

  198. Papale JJ, Akiwama K, Hirose T, Tsubota K, Hanaoka K, Albert DM. Adenocarcinoma of the ciliary body pigment epithelium in a child. Arch Ophthalmol. 1984;102:100–3.

    CAS  PubMed  Google Scholar 

  199. Terasaki H, Nagasaka T, Arai M, Harada T, Miyake Y. Adenocarcinoma of the nonpigmented ciliary epithelium: report of two cases with immunohistochemical findings. Graefes Arch Clin Exp Ophthalmol. 2001;239(11):876–81.

    CAS  PubMed  Google Scholar 

  200. Chang M, Shields JA, Wachtel DL. Adenoma of the pigment epithelium of the ciliary body simulating a malignant melanoma. Am J Ophthalmol. 1979;88:40–4.

    CAS  PubMed  Google Scholar 

  201. Wilensky JT, Holland MG. A pigmented tumor of the ciliary body. Arch Ophthalmol. 1974;92:219–20.

    CAS  PubMed  Google Scholar 

  202. Rodrigues M, Hidayat A, Karesh J. Pleomorphic adenocarcinoma of ciliary epithelium simulating an epibulbar tumour. Am J Ophthalmol. 1988;106:595–600.

    CAS  PubMed  Google Scholar 

  203. Broughton WL, Zimmerman LE. A clinicopathologic study of 56 cases of intraocular medulloepithelioma. Am J Ophthalmol. 1978;85:407–18.

    CAS  PubMed  Google Scholar 

  204. Kivela T, Tarkkanen A. Recurrent medulloepithelioma of the ciliary body: immunohistochemical characteristics. Ophthalmology. 1988;95:1565–75.

    CAS  PubMed  Google Scholar 

  205. Shields JA, Eagle RC, Shields CL, De Potter P. Congenital neoplasms of the nonpigmented ciliary epithelium (medulloepithelioma). Ophthalmology. 1996;103:1998–2006.

    CAS  PubMed  Google Scholar 

  206. Wakakura M, Lee WR. Ultrastructural pleomorphism in medulloepithelioma of the ciliary body: a comparative study of tumour cells and fetal ciliary epithelium. Jap J Ophthalmol. 1990;34:364–80.

    CAS  Google Scholar 

  207. Saunders T, Margo CE. Intraocular medulloepithelioma. Arch Pathol Lab Med. 2012;136:212–6.

    CAS  PubMed  Google Scholar 

  208. Husain SE, Husain N, Boniuk M, Font RL. Malignant non-teratoid medulloepithelioma of the ciliary body in an adult. Ophthalmology. 1998;105:596–9.

    CAS  PubMed  Google Scholar 

  209. Zimmerman LE, Broughton WL. A clinicopathologic and followup study of fifty-six intraocular medulloepitheliomas. In: Jakobiec FA, editor. Ocular adnexal tumors. Birmingham: Aesculapius Publishing; 1978. p. 181–96.

    Google Scholar 

  210. Vadmal M, Kahn E, Finger P, Teichberg S. Nonteratoid medulloepithelioma of the retina with electron microscopic and immunohistochemical characterization. Pediatr Pathol Lab Med. 1996;16(5):663–72.

    CAS  PubMed  Google Scholar 

  211. Sosińska-Mielcarek K, Senkus-Konefka E, Jaskiewicz K, Kordek R, Jassem J. Intraocular malignant teratoid medulloepithelioma in an adult: clinicopathological case report and review of the literature. Acata Ophthalmol Scand. 2006;84(2):259–62.

    Google Scholar 

  212. Al-Salam S, Algawi K, Alashari M. Malignant non-teratoid medulloepithelioma of the ciliary body with retinoblastic differentiation: a case report and review of literature. Neuropathology. 2008;28(5):551–6.

    PubMed  Google Scholar 

  213. Cerase A, De Francesco S, Citterio A, Hadjistilianou T, Malandrini A, Mastrangelo D, et al. Growth of congenital malignant teratoid medulloepithelioma of the ciliary body: a case study. J Neurooncol. 2010;96(3):443–8.

    PubMed  Google Scholar 

  214. Kivela T, Merenmies L, Ilveskoski I, Tarkkanen A. Congenital ocular teratoma. Ophthalmology. 1993;100:782–91.

    CAS  PubMed  Google Scholar 

  215. Steinkuller PG, Font RL. Congenital malignant teratoid neoplasm of the eye and orbit. Ophthalmology. 1997;104:38–42.

    CAS  PubMed  Google Scholar 

  216. Canning CR, McCartney AC, Hungerford J. Medulloepithelioma (diktyoma). Br J Ophthalmol. 1988;72(10):764–7.

    CAS  PubMed  Google Scholar 

  217. Cassoux N, Charlotte F, Sastre X, Orbach D, Lehoang P, Desjardins L. Conservative surgical treatment of medulloepithelioma of the ciliary body. Arch Ophthalmol. 2010;128(3):380–1.

    PubMed  Google Scholar 

  218. Davidorf FH, Craig E, Birnbaum L, Wakely Jr P. Management of medulloepithelioma of the ciliary body with brachytherapy. Am J Ophthalmol. 2002;133(6):841–3.

    PubMed  Google Scholar 

  219. Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. Arch Ophthalmol. 1974;92:276–86.

    CAS  PubMed  Google Scholar 

  220. Riddle PJ, Font RL, Zimmerman LE. Carcinoid tumours of the eye and orbit. Hum Pathol. 1982;13:459–69.

    CAS  PubMed  Google Scholar 

  221. Chan C-C, Pack S, Pak E, Tsogos M, Zhuang Z. Translocation of chromosomes 11 and 22 in choroidal metastatic Ewing sarcoma detected by fluorescent in situ hybridisation. Am J Ophthalmol. 1999;127:226–8.

    CAS  PubMed  Google Scholar 

  222. Nelson CC, Hertzberg BS, Klintworth GK. A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol. 1983;95:788–93.

    CAS  PubMed  Google Scholar 

  223. Desroches G, Abrams GW, Gass JDM. Reactive lymphoid hyperplasia of the uvea. Arch Ophthalmol. 1983;101:725–8.

    CAS  PubMed  Google Scholar 

  224. Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM. Re-evaluation of “reactive lymphoid hyperplasia” of the uvea: immunohistochemical and molecular analysis of 10 cases. Ophthalmology. 2000;107:151–8.

    CAS  PubMed  Google Scholar 

  225. Da Cruz L, James B, Gray R, Elston J. Multiple vortex vein varices masquerading as choroidal secondaries. Br J Ophthalmol. 1994;78:800–1.

    PubMed  Google Scholar 

  226. Tsipursky MS, Golchet PR, Jampol LM. Photodynamic therapy of choroidal hemangioma in Sturge-Weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol. 2011;56(1):68–85.

    PubMed  Google Scholar 

  227. Anand R. Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome. Am J Ophthalmol. 2003;136(4):758–60.

    PubMed  Google Scholar 

  228. Schilling H, Sauerwein W, Lommatzsch A, Friedrichs W, Brylak S, Bornfeld N, et al. Long term results after low dose ocular irradiation for choroidal melanomas. Br J Ophthalmol. 1997;81:267–73.

    CAS  PubMed  Google Scholar 

  229. Gottlieb JL, Murray TG, Gass JD. Low-dose external beam irradiation for bilateral diffuse choroidal hemangioma. Arch Ophthalmol. 1998;116(6):815–7.

    CAS  PubMed  Google Scholar 

  230. Ritland JS, Eide N, Tausjo J. External beam irradiation therapy for choroidal haemangiomas. Visual and anatomical results after a dose of 20 to 25 Gy. Acta Ophthalmol Scand. 2001;79(2):184–6.

    CAS  PubMed  Google Scholar 

  231. Zografos L, Egger E, Bercher L, Chamot L, Munkel G. Proton beam irradiation of choroidal hemangiomas. Am J Ophthalmol. 1998;126(2):261–8.

    CAS  PubMed  Google Scholar 

  232. Zografos L, Bercher L, Chamot L, Gailloud C, Raimondi S, Egger E. Cobalt 60 treatment of choroidal haemangiomas. Am J Ophthalmol. 1996;1221:160–9.

    Google Scholar 

  233. Murthy R, Hanovaz SG, Naik M, Gopi S, Reddy VA. Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal haemangioma in Sturge-Weber syndrome. Indian J Ophthalmol. 2005;53(4):274–5.

    PubMed  Google Scholar 

  234. Singh AD, Rundle PA, Vardy SJ, Rennie IG. Photodynamic therapy of choroidal haemangioma associated with Sturge-Weber syndrome. Eye. 2005;19(3):365–7.

    CAS  PubMed  Google Scholar 

  235. Huiskamp EA, Müskens RP, Ballast A, Hooymans JM. Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia. Graefes Arch Clin Exp Ophthalmol. 2005;243(7):727–30.

    CAS  PubMed  Google Scholar 

  236. Paulus YM, Jain A, Moshfeghi DM. Resolution of persistent exudative retinal detachment in a case of Sturge-Weber syndrome with anti-VEGF administration. Ocul Immunol Inflamm. 2009;17(4):292–4.

    PubMed  Google Scholar 

  237. Madreperla SA, Hungerford JL, Plowman PN, Laganowski HC, Gregory PT. Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology. 1997;104(11):1773–8.

    CAS  PubMed  Google Scholar 

  238. Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology. 2001;108(12):2237–48.

    CAS  PubMed  Google Scholar 

  239. Gunduz K. Transpupillary thermotherapy in the management of circumscribed choroidal hemangioma. Surv Ophthalmol. 2004;49(3):316–27.

    PubMed  Google Scholar 

  240. Jurklies B, Anastassiou G, Ortmans S, Schüler A, Schilling H, Schmidt-Erfurth U, et al. Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol. 2003;87(1):84–9.

    CAS  PubMed  Google Scholar 

  241. Michels S, Michels R, Simader C, Schmidt-Erfurth U. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina. 2005;25(6):697–703.

    PubMed  Google Scholar 

  242. Sagong M, Lee J, Chang W. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol. 2009;23(2):127–31.

    PubMed  Google Scholar 

  243. Shields CL, Shields JA, Augsburger JJ. Choroidal osteoma. Surv Ophthalmol. 1988;33:17–27.

    CAS  PubMed  Google Scholar 

  244. Shields CL, Sun H, Demiric H, Shilds JA. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol. 2005;123:1658–66.

    PubMed  Google Scholar 

  245. Gass JD, Guerry RK, Jack RL, Harris G. Choroidal osteoma. Arch Ophthalmol. 1978;96:428–35.

    CAS  PubMed  Google Scholar 

  246. Williams AT, Font RL, Van Dyk HJL, Riekhof FT. Osseous choristoma of the choroid simulating a choroidal melanoma: association with a positive 32P test. Arch Ophthalmol. 1978;96:1874–7.

    CAS  PubMed  Google Scholar 

  247. Joffe L, Shields JA, Fitzgerald J. Osseous choristoma of the choroid. Arch Ophthalmol. 1978;96:1809–12.

    CAS  PubMed  Google Scholar 

  248. Baum MD, Pilkerton AR, Berler DK, Kramer KK. Choroidal osteoma. Ann Ophthalmol. 1979;11:1849–51.

    CAS  PubMed  Google Scholar 

  249. Loose IA, Jampol LM, O’Grady R. Pigmented adenoma mimicking a juxtapapillary melanoma. Arch Ophthalmol. 1999;117(1):120–2.

    CAS  PubMed  Google Scholar 

  250. Shields JA, Melki T, Shields CL, Eagle Jr RC, Singh AD. Epipapillary adenoma of the retinal pigment epithelium. Retina. 2001;21(1):76–8.

    CAS  PubMed  Google Scholar 

  251. Sommacal A, Campbell RJ, Helbig H. Adenocarcinoma of the retinal pigment epithelium. Arch Ophthalmol. 2003;121(10):1481–3.

    PubMed  Google Scholar 

  252. Wei W, Mo J, Jie Y, Li B. Adenoma of the retinal pigment epithelium: a report of 3 cases. Can J Ophthalmol. 2010;45(2):166–70.

    PubMed  Google Scholar 

  253. Nakamura S, Hikita N, Yamakawa R, Moriya F, Yano H, Furusato E, Cameron JD, Rushing EJ. A clinically challenging diagnosis of adenoma of the retinal pigment epithelium presenting with clinical features of choroidal hemangioma. Clin Ophthalmol. 2012;6:497–502.

    PubMed  Google Scholar 

  254. Shields JA, Eagle RC, Shields CL, De Potter P. Pigmented adenoma of the optic nerve head simulating a melanocytoma. Ophthalmology. 1992;99:1705–8.

    CAS  PubMed  Google Scholar 

  255. Loeffler KU, Kivela T, Borgmann H, Witschel H. Malignant tumour of the retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 1996;234:S70–5.

    PubMed  Google Scholar 

  256. Finger PT, McCormick SA, Davidian M, Walsh JB. Adenocarcinoma of the retinal pigment epithelium: a diagnostic and therapeutic challenge. Graefes Arch Clin Exp Ophthalmol. 1996;234:S22–7.

    PubMed  Google Scholar 

  257. Shields JA, Shields CL, Singh AD. Acquired tumours arising from congenital hypertrophy of the retinal pigment epithelium. Arch Ophthalmol. 2000;118:637–41.

    CAS  PubMed  Google Scholar 

  258. Shields JA, Eagle Jr RC, Shields CL, Brown GC, Lally SE. Malignant transformation of congenital hypertrophy of the retinal pigment epithelium. Ophthalmology. 2009;116(11):2213–6.

    PubMed  Google Scholar 

  259. Wirz K, Lee WR, Coaker T. Progressive changes in congenital hypertrophy of the retinal pigment epithelium. A. Graefes Arch Klin Exp Ophthalmol. 1982;219:214–21.

    CAS  Google Scholar 

  260. Chapman PD, Church W, Burn J, Gunn A. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. Br Med J. 1989;298:6670.

    Google Scholar 

  261. Martow J, Polomeno RC, Lewandowski R, Daly D, Miller S, Jutras L, et al. The importance of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Can J Ophthalmol. 1990;25:290–2.

    CAS  PubMed  Google Scholar 

  262. Munden PM, Sobol WM, Weingeist TA. Ocular findings in Turcot syndrome (glioma-polyposis). Ophthalmology. 1991;98:111–4.

    CAS  PubMed  Google Scholar 

  263. Font RL, Moura RA, Shetlar DJ, Martinez JA, McPherson AR. Combined hamartoma of sensory retina and retinal pigment epithelium. Retina. 1989;9:302–11.

    CAS  PubMed  Google Scholar 

  264. Irvine F, O’Donnell N, Kemp E, Lee WR. Retinal vasoproliferative tumours: surgical management and histological findings. Arch Ophthalmol. 2000;118:563–9.

    CAS  PubMed  Google Scholar 

  265. Brubaker RF, Pederson JE. Ciliochoroidal detachment. Surv Ophthalmol. 1983;27:281–9.

    CAS  PubMed  Google Scholar 

  266. Forrester JV, Lee WR, Kerr PR, Dua HS. The uveal effusion syndrome and transscleral flow. Eye. 1990;4:354–65.

    PubMed  Google Scholar 

  267. Uyama M, Takahashi K, Kozaki J, Tagami N, Takada Y, Ohkuma H, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera and pathophysiology. Ophthalmology. 2000;107:441–9.

    CAS  PubMed  Google Scholar 

  268. Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: a review. Semin Ophthalmol. 2006;21(3):125–33.

    PubMed  Google Scholar 

  269. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthal. 2008;36:564–78.

    Google Scholar 

  270. Vosganian GS, Boisot S, Hartmann KI, Freeman WR, Sharpe RW, Tripuraneni P, Saven A. Primary intraocular lymphoma: a review. J Neurooncol. 2011;105(2):127–34.

    PubMed  Google Scholar 

  271. Pe’er J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009;17:299–306.

    PubMed  Google Scholar 

  272. Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004;242:901–13.

    PubMed  Google Scholar 

  273. Schanzer MC, Font RL, O’Malley RE. Primary ocular malignant lymphoma associated with the acquired immune deficiency syndrome. Ophthalmology. 1991;98:88–91.

    CAS  PubMed  Google Scholar 

  274. Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am. 2005;19:739–49. viii.

    PubMed  Google Scholar 

  275. Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11:285–95.

    PubMed  Google Scholar 

  276. Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Socn. 2003;101:275–92.

    Google Scholar 

  277. Cochereau I, Hannouche D, Geoffray C, Toublanc M, Hoang-Xuan T. Ocular involvement in Epstein-Barr virus-associated T-cell lymphoma. Am J Ophthalmol. 1996;121:322–4.

    CAS  PubMed  Google Scholar 

  278. Behbehani R, Mathews MK, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol. 2005;139(3):518–21.

    PubMed  Google Scholar 

  279. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoeitic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.

    Google Scholar 

  280. Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ. Primary intraocular T-cell-rich large B-cell lymphoma. Arch Pathol Lab Med. 2005;129(8):1050–3.

    PubMed  Google Scholar 

  281. Goldey SH, Stern GA, Oblon DJ, Mendenhall NP, Smith LJ, Duque RE. Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report. Arch Ophthalmol. 1989;107:1349–53.

    CAS  PubMed  Google Scholar 

  282. Coupland SE, Anastassiou G, Bornfeld N, Hummel M, Stein H. Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2005;243(3):189–97.

    PubMed  Google Scholar 

  283. Saenz AD, Amador A, Ruiz BM, Davis J, Ruiz P. Cytofluorographic and molecular identification of a CD8- positive, TCR-alpha/beta-negative intraocular T cell lymphoma: a case report and review of the literature. J Med Case Rep. 2007;1:114.

    PubMed  Google Scholar 

  284. Guyer DR, Green WR, Schachat AP, Bastacky S, Miller NR. Bilateral ischaemic optic neuropathy and retinal vascular occlusions associated with lymphoma and sepsis. Ophthalmology. 1990;97:882–8.

    CAS  PubMed  Google Scholar 

  285. Brown SM, Jampol LM, Cantrill HL. Intraocular lymphoma presenting as retinal vasculitis. Surv Ophthalmol. 1995;39:133–40.

    Google Scholar 

  286. Coupland SE, Joussen A, Anastassiou G, Stein H. Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report. Graefes Arch Clin Exp Ophthalmol. 2005;243:482–6.

    PubMed  Google Scholar 

  287. Jakobiec FA, Sacks E, Kronish JW, Weiss T, Smith M. Multifocal static creamy choroidal infiltrates. An early sign of lymphoid neoplasia. Ophthalmology. 1987;94(4):397–406.

    CAS  PubMed  Google Scholar 

  288. Ciulla TA, Bains RA, Jakobiec FA, Topping TM, Gragoudas ES. Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. Surv Ophthalmol. 1997;41:467–76.

    CAS  PubMed  Google Scholar 

  289. Holz FG, Boehmer HV, Mechtersheimer G, Ott G, Volcker HE. Uveal non-Hodgkin’s lymphoma with epibulbar extension simulating choroidal effusion syndrome. Retina. 1999;19:343–6.

    CAS  PubMed  Google Scholar 

  290. Coupland SE, Foss HD, Hidayat AA, Cockerham GC, Hummel M, Stein H. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol. 2002;197:333–40.

    PubMed  Google Scholar 

  291. Coupland SE, Damato B. Lymphomas involving the eye and the ocular adnexa. Curr Opin Ophthalmol. 2006;17:523–31.

    PubMed  Google Scholar 

  292. Jensen OA, Johansen S, Kiss K. Intraocular T-cell lymphoma mimicking a ring melanoma. first manifestation of systemic disease. Graefes Arch Clin Exp Ophthalmol. 1994;232:148–52.

    CAS  PubMed  Google Scholar 

  293. Yahalom C, Cohen Y, Averbukh E, Anteby I, Amir G, Pe’er J. Bilateral iridociliary T-cell lymphoma. Arch Ophthalmol. 2002;120:204–7.

    PubMed  Google Scholar 

  294. Lobo A, Larkin G, Clark BJ, Towler HM, Lightman S. Pseudohypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Experiment Ophthalmol. 2003;31:155–8.

    PubMed  Google Scholar 

  295. Yamada K, Hirata A, Kimura A, Tanihara H. A case of primary B-cell type non-Hodgkin lymphoma originating in the iris. Am J Ophthalmol. 2003;136:380–2.

    PubMed  Google Scholar 

  296. Verbraeken HE, Hanssens M, Priem H, Lafaut BA, De Laey JJ. Ocular non-Hodgkin’s lymphoma: a clinical study of nine cases. Br J Ophthalmol. 1997;81:31–6.

    CAS  PubMed  Google Scholar 

  297. Parikh AH, Sameer HK, Wright Jr JD, Kean TO. Systemic Non-Hodgkin’s lymphoma simulating primary intraocular lymphoma. Am J Ophthalmol. 2005;139:573–4.

    PubMed  Google Scholar 

  298. Shakin EP, Augsburger JJ, Eagle RC, Ehya H, Shields JA, Fischer D, Koepsell DG. Multiple myeloma involving the iris. Arch Ophthalmol. 1988;106:524–6.

    CAS  PubMed  Google Scholar 

  299. Tranos PG, Andreou PG, Wickremasinghe SS, Brazier JD. Pseudohypopyon as a feature of multiple myeloma. Arch Ophthalmol. 2002;120:87–8.

    PubMed  Google Scholar 

  300. Duker JS, Shields JA, Ross M. Intraocular large cell lymphoma presenting as massive thickening of the uveal tract. Retina. 1987;7:41–5.

    CAS  PubMed  Google Scholar 

  301. Fredrick DR, Char DH, Ljung BM, Brinton DA. Solitary intraocular lymphoma as an initial presentation of widespread disease. Arch Ophthalmol. 1989;107:395–7.

    CAS  PubMed  Google Scholar 

  302. Orellana J, Friedman AH. Ocular manifestations of multiple myeloma, Waldenstrom’s macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol. 1981;26:157–69.

    CAS  PubMed  Google Scholar 

  303. Knapp AJ, Gartner S, Henkind P. Multiple myeloma and its ocular manifestations. Surv Ophthalmol. 1987;31:343–51.

    CAS  PubMed  Google Scholar 

  304. Honavar SG, Shields JA, Shields CL, Demirci H, Ehya H. Extramedullary plasmacytoma confined to the choroid. Am J Ophthalmol. 2001;131:277–8.

    CAS  PubMed  Google Scholar 

  305. Pinna A, Dore S, Dore F, Salis A, Carta F. Bilateral optic disc swelling as the presenting sign of Waldenströms macroglobulinaemia. Acta Ophthalmol Scand. 2003;81:413–5.

    PubMed  Google Scholar 

  306. Sen NH, Chan CC, Caruso RC, Fariss RN, Nussenblatt RB, Buggage RR. Waldenström’s macroglobulinemia-associated retinopathy. Ophthalmology. 2004;111:535–9.

    PubMed  Google Scholar 

  307. Pilon AF, Rhee P, Messner LV. Bilateral, persistent serous macular detachments with Waldenström’s macroglobulinemia. Optom Vis Sci. 2005;82:573–8.

    PubMed  Google Scholar 

  308. Kincaid ME, Green WR. Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983;27:211–32.

    CAS  PubMed  Google Scholar 

  309. Coupland SE, Foss HD, Bechrakis NE, Hummel M, Stein H. Secondary ocular involvement in systemic ‘memory’ B-cell lymphocytic leukemia. Ophthalmology. 2001;108:1289–95.

    CAS  PubMed  Google Scholar 

  310. Jahnke K, Thiel E, Schilling A, Herrlinger U, Weller M, Coupland SE, et al. Low-grade primary central nervous system lymphoma in immunocompetent patients. Br J Haematol. 2005;128:616–24.

    PubMed  Google Scholar 

  311. Payne T, Karp LA, Zimmerman LE. Intraocular involvement in Burkitt’s lymphoma. Arch Ophthalmol. 1971;85:295–8.

    CAS  PubMed  Google Scholar 

  312. Wysenbeek YS, Nissenkorn I, Cohen S, Ben-Sira I, Stark B, Zaizov R. Intraocular involvement of Burkitt’s lymphoma in a Bedouin child. Pediatr Hematol Oncol. 1987;4:309–14.

    CAS  PubMed  Google Scholar 

  313. Mudhar HS, Sethuraman C, Khan MD, Jan SU. Intracular, pan-uveal intravascular large B-cell lymphoma associated with choroidal infarction and choroidal tri-lineage extramedullary haemtopoiesis. Histopathology. 2007;51:275–9.

    CAS  PubMed  Google Scholar 

  314. Sen HN, Bodaghi B, Hoang PL, Nussenblatt R. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm. 2009;17:133–41.

    CAS  PubMed  Google Scholar 

  315. Gulla TA, Bams RA, Jakobiec FA, Topping TM, Gragoudas ES. Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. Surv Ophthalmol. 1997;41:467–76.

    Google Scholar 

  316. Davis JL, Viciana A, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol. 1997;124:362–72.

    CAS  PubMed  Google Scholar 

  317. Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27(4):241–50.

    PubMed  Google Scholar 

  318. Coupland SE, Perez-Canto A, Hummel M, Stein H, Heimann H. Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome). Graefes Arch Clin Exp Ophthalmol. 2005;243:847–52.

    PubMed  Google Scholar 

  319. Faia LJ, Chan CC. Primary intraocular lymphoma. Arch Pathol Lab Med. 2009;133:1228–32.

    CAS  PubMed  Google Scholar 

  320. Buggage RR, Velez G, Meyers-Powell B, Shen D, Whitcup SM, Chan C-C. Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH rearrangement. Arch Ophthalmol. 1999;117:1239–42.

    CAS  PubMed  Google Scholar 

  321. Wolf LA, Reed GF, Buggage RR, Nussenblatt RB, Chan CC. Vitreous cytokine levels. Ophthalmology. 2003;110(8):1671–2.

    PubMed  Google Scholar 

  322. Abramson DH, Ellsworth RM, Grumbach N, Kitchen FD. Retinoblastoma: Survival, age at detection and comparison 1914–1958, 1958–1983. J Paediatr Ophthalmol Strabismus. 1985;22:246–50.

    CAS  Google Scholar 

  323. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.

    PubMed  Google Scholar 

  324. Mietz H, Hutton WL, Font RL. Unilateral retinoblastoma in an adult. Ophthalmology. 1997;104:43–7.

    CAS  PubMed  Google Scholar 

  325. Shields JA, Shields CL, Parsons H, Giplin ME. The role of photocoagulation in the management of retinoblastoma. Arch Ophthalmol. 1990;108:205–8.

    CAS  PubMed  Google Scholar 

  326. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12–7.

    CAS  PubMed  Google Scholar 

  327. Char DH, Kaleta-Michaels S, Kingston JE. Metastatic retinoblastoma. Arch Ophthalmol. 1989;107:1570–1.

    CAS  PubMed  Google Scholar 

  328. Parsam VL, Ali MJ, Honavar SG, Vemuganti GK, Kannabiran C. Splicing aberrations caused by constitutional RB1 gene mutations in retinoblastoma. J Biosci. 2011;36(2):281–7.

    CAS  PubMed  Google Scholar 

  329. De Luca A, Esposito V, Baldi A, Giordano A. The retinoblastoma gene family and its role in proliferation, differentiation and development. Histol Histopathol. 1996;11:1029–34.

    PubMed  Google Scholar 

  330. Yilmaz S, Horsthemke B, Lohmann DR. Twelve novel RB1 gene mutations in patients with hereditary retinoblastoma. Hum Mutat. 1998;12:434.

    CAS  PubMed  Google Scholar 

  331. Harbour JW. Eye cancer: unique insights into oncogenesis: the Cogan Lecture. Invest Ophthalmol Vis Sci. 2006;47(5):1736–45.

    PubMed  Google Scholar 

  332. Valverde JR, Alonso J, Palacios I, Pestana A. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet. 2005;6:53.

    PubMed  Google Scholar 

  333. Damjanovich J, Adany R, Berta A, Beck Z, Balazs M. Mutation of the RB1 gene caused unilateral retinoblastoma in early age. Cancer Genet Cytogenet. 2000;119:1–7.

    CAS  PubMed  Google Scholar 

  334. Whitcup SM, Park WS, Gasch AT, Eagle RC, Filie AC, Nussenblatt RB, et al. Use of microdissection and molecular genetics in the pathologic diagnosis of retinoblastoma. Retina. 1999;19:318–24.

    CAS  PubMed  Google Scholar 

  335. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet. 2003;72(2):253–69.

    CAS  PubMed  Google Scholar 

  336. Houdayer C, Gauthier-Villars M, Laugé A, Pagès-Berhouet S, Dehainault C, Caux-Moncoutier V, et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat. 2004;23(2):193–202.

    CAS  PubMed  Google Scholar 

  337. Parsam VL, Kannabiran C, Honavar S, Vemuganti GK, Ali MJ. A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma. J Genet. 2009;88(4):517–27.

    CAS  PubMed  Google Scholar 

  338. Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008;15(17):1363–72.

    Google Scholar 

  339. Dudgeon J, Lee WR. The trilateral retinoblastoma syndrome. Trans Ophthalmol Soc UK. 1984;103:523–9.

    Google Scholar 

  340. Pesin SR, Shields JA. Seven cases of trilateral retinoblastoma. Am J Ophthalmol. 1989;107:121–6.

    CAS  PubMed  Google Scholar 

  341. Kivela T. Trilateral retinoblastoma: a meta analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clinical Oncology. 1999;17:1829–37.

    CAS  Google Scholar 

  342. Marcus DMM, Brooks SE, Leff G, McCormick R, Thompson T, Anfinson S, et al. Trilateral retinoblastoma: insights into histogenesis and management. Surv Ophthalmol. 1998;43:59–70.

    CAS  PubMed  Google Scholar 

  343. Meadows AT, Leahey AM. More about second cancers after retinoblastoma. J Natl Cancer Inst. 2008;100:1743–5.

    PubMed  Google Scholar 

  344. De Potter P, Shields CL, Shields JA. Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Paediatr Ophthalmol Strabismus. 1994;31:26–31.

    Google Scholar 

  345. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986;53:661–71.

    CAS  PubMed  Google Scholar 

  346. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95:1583–7.

    CAS  PubMed  Google Scholar 

  347. Pratt CB, Michalkiewicz EN, Rao BN, Lipson M, Cain A, Kaste S. Multifocal osteosarcoma following retinoblastoma. Ophthalmic Genet. 1999;20:23–9.

    CAS  PubMed  Google Scholar 

  348. Wenzel CT, Halperin EC, Fisher SR. Second malignant neoplasms of the head and neck in survivors of retinoblastoma. Ear Nose Throat J. 2001;80(106):109–12.

    Google Scholar 

  349. Abramson DH. The focal treatment of retinoblastoma with emphasis on xenon arc photocoagulation. Acta Ophthalmol Suppl. 1989;194:3–63.

    CAS  PubMed  Google Scholar 

  350. Pe’er J, Neufeld M, Baras M, Gnessin H, Itin A, Keshet E. Rubeosis iridis in retinoblastoma. Ophthalmology. 1997;104:1251–8.

    PubMed  Google Scholar 

  351. Liang JC, Ausburger JJ, Shields JA. Diffuse infiltrating retinoblastoma associated with persistent primary vitreous. J Paediatr Ophthalmol Strabismus. 1985;22:31–3.

    CAS  Google Scholar 

  352. Kindy-Degnan NA, Char DH, Castro JR, Kroll S, Stone RD, Quivey JM, et al. Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications and survival. Am J Ophthalmol. 1989;107:114–20.

    CAS  PubMed  Google Scholar 

  353. Marcus DM, Craft JL, Albert DM. Histopathologic verification of Verhoeff’s 1918 irradiation cure of retinoblastoma. Ophthalmology. 1990;97:221–4.

    CAS  PubMed  Google Scholar 

  354. Shields CL, Shields JA, De Potter P, Minelli S, Hernandez C, Brady LW, et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology. 1993;100:216–24.

    CAS  PubMed  Google Scholar 

  355. Abramson DH, Greenfield DS, Ellsworth RM. Neuron-specific enolase and retinoblastoma. Clinicopathologic correlations. Retina. 1989;9:148–52.

    CAS  PubMed  Google Scholar 

  356. Ohnishi Y, Yamana Y, Minei M. Photoradiation therapy using argon laser and a haematoporphyrin derivatives for retinoblastoma – a preliminary report. Jpn J Ophthalmol. 1986;30:409–19.

    CAS  PubMed  Google Scholar 

  357. Winther JB. The effect of photodynamic therapy on a retinoblastoma-like tumour. Acta Ophthalmol. 1990;68:1–37.

    Google Scholar 

  358. Akiyama K, Iwasaki M, Amemiya T, Tanai M. Chemotherapy for retinoblastoma. Ophthalmol Paediatr Genet. 1989;10:111–6.

    CAS  Google Scholar 

  359. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1339–43.

    CAS  PubMed  Google Scholar 

  360. Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348–56.

    CAS  PubMed  Google Scholar 

  361. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330–8.

    CAS  PubMed  Google Scholar 

  362. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108:260–4.

    CAS  PubMed  Google Scholar 

  363. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: long term control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116–21.

    CAS  PubMed  Google Scholar 

  364. Mehta M, Sethi S, Pushker N, Kashyap S, Sen S, Bajaj MS, Ghose S. Retinoblastoma. Singapore Med J. 2012;53(2):128–36.

    CAS  PubMed  Google Scholar 

  365. Imperia PS, Lazarus HN, Lass JH. Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol. 1989;34:209–30.

    CAS  PubMed  Google Scholar 

  366. Nahum MP, Gdal-On M, Kuten A, Herzl G, Horovitz Y, Weyl Ben Arush M. Long-term follow-up of children with retinoblastoma. Pediatr Hematol Oncol. 2001;18:173–9.

    CAS  PubMed  Google Scholar 

  367. Bechrakis NE, Bornfeld N, Scheuler A, Coupland SE, Henze G, Foerster MH. Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Opthalmol. 1998;116:887–93.

    CAS  Google Scholar 

  368. Dithmar S, Aabert JM, Grossniklaus HE. Histopathologic changes in retinoblastoma after chemoreduction. Retina. 2000;20:33–6.

    CAS  PubMed  Google Scholar 

  369. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma. Metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77:544–8.

    CAS  PubMed  Google Scholar 

  370. Mullaney PB, Karcioglu ZA, Huaman AM, Al-Mesfer SA. Retinoblastoma associated orbital cellulitis. Br J Ophthalmol. 1998;82:517–21.

    CAS  PubMed  Google Scholar 

  371. Materin MA, Shields CL, Shields JA, Eagle RC. Diffuse infiltrating retinoblastoma simulating uveitis in a seven year old boy. Arch Ophthalmol. 2000;118:442–3.

    CAS  PubMed  Google Scholar 

  372. Howard MA, Dryja TP, Walton DS, Albert DM. Identification and significance of multinucleate cells in retinoblastoma. Arch Ophthalmol. 1989;107:1025–38.

    CAS  PubMed  Google Scholar 

  373. Rodrigues MM, Wiggert B, Shields J, Donoso L, Bardenstein D, Katz N, et al. Retinoblastoma. Immunohistochemistry and cell differentiation. Ophthalmology. 1987;94:378–87.

    CAS  PubMed  Google Scholar 

  374. Nork TM, Millecchia LL, de Venecia GB, Myers FL, Vogel KA. Immunocytochemical features of retinoblastoma in an adult. Arch Ophthalmol. 1996;114:1402–6.

    CAS  PubMed  Google Scholar 

  375. Tso MOM. Clues to the cells of origin in retinoblastoma. In: Albert DM, Weichselbaum RR, editors. Advances regarding the pathogenesis and treatment of ocular tumours. Boston: Little Brown and Co; 1980. p. 191–210.

    Google Scholar 

  376. Messmer EP, Font RL, Kirkpatrick JB, Hopping W. Immunohistochemical demonstration of neuronal and astrocytic differentiation in retinoblastoma. Ophthalmology. 1985;92:167–73.

    CAS  PubMed  Google Scholar 

  377. Shuangshoti S, Chaiwun B, Kasantikul V. A study of 39 retinoblastomas with particular reference to morphology, cellular differentiation and tumour origin. Histopathology. 1989;15:113–24.

    CAS  PubMed  Google Scholar 

  378. Eagle Jr RC. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133:1203–9.

    PubMed  Google Scholar 

  379. Cha SC, Suh KS, Song KS, Lim K. Cell death in retinoblastoma: electron microscopic, immunohistochemical and DNA fragmentation studies. Ultrastruct Pathol. 2000;24:23–32.

    CAS  PubMed  Google Scholar 

  380. Karcioglu ZA. Fine needle aspiration biopsy (FNAB) for retinoblastoma. Retina. 2002;22(6):707–10.

    PubMed  Google Scholar 

  381. Magram I, Abrahamson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217–22.

    Google Scholar 

  382. Messmer EP, Heinrich T, Höpping W, de Sutter E, Havers W, Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98:136–41.

    CAS  PubMed  Google Scholar 

  383. Eagle Jr RC. The pathology of ocular cancer. Eye (Lond). 2013;27(2):128–36.

    CAS  Google Scholar 

  384. Margo C, Hidayat A, Kopelman J, Zimmerman LE. Retinocytoma. Arch Ophthalmol. 1983;101:1519–31.

    CAS  PubMed  Google Scholar 

  385. Singh AD, Carmen M, Shields CL, Shields JA, Eagle RC. Observations on 17 patients with retinocytoma. Arch Ophthalmol. 2000;118:199–205.

    CAS  PubMed  Google Scholar 

  386. Hadjistilianou T, De Francesco S, Martone G, Malandrini A. Retinocytoma associated with vitreous deposits. Eur J Ophthalmol. 2006;16:349–51.

    CAS  PubMed  Google Scholar 

  387. Naseripour M, Falavarjani KG, Akbarzadeh S. Retinocytoma associated with bilateral retinoblastoma. Indian J Ophthalmol. 2010;58(2):155–6.

    PubMed  Google Scholar 

  388. Arnold AC, Hepler RS, Yee RW, Maggiano J, Eng LF, Foos RY. Solitary retinal astrocytoma. Surv Ophthalmol. 1985;30:173–81.

    CAS  PubMed  Google Scholar 

  389. Drewe RH, Lee WR. Solitary astrocytic hamartoma simulating retinoblastoma. Ophthalmologica. 1985;190:158–67.

    CAS  PubMed  Google Scholar 

  390. Foos RY. Solitary retinal astrocytoma. Surv Ophthalmol. 1985;30:173–81.

    PubMed  Google Scholar 

  391. Williams R, Taylor D. Tuberous sclerosis. Surv Ophthalmol. 1985;30:143–54.

    CAS  PubMed  Google Scholar 

  392. Lee JA, Harvey P, Finlay RD, Berry PJ. Solitary astrocytoma of the retina in a child. Br J Ophthalmol. 1996;80:674–5.

    CAS  PubMed  Google Scholar 

  393. Shields CL, Shields JA, Eagle Jr RC, Cangemi F. Progressive enlargement of acquired retinal astrocytoma in 2 cases. Ophthalmology. 2004;111(2):363–8.

    PubMed  Google Scholar 

  394. Shields JA, Shields CL, Ehya H, Buckley E, De Potter P. Atypical retinal astrocytic hamartoma diagnosed by fine-needle biopsy. Ophthalmology. 1996;103:949–52.

    CAS  PubMed  Google Scholar 

  395. Kivela T, Kauniskangas L, Miettinen P, Tarkkanen A. Glioneuroma associated with colobomatous dysplasia of the anterior uvea and retina. A case simulating medulloepithelioma. Ophthalmology. 1989;96:1799–808.

    CAS  PubMed  Google Scholar 

  396. Metcalf C, Mele EM, McAllister I. Neurocytoma of the retina. Br J Ophthalmol. 1993;77:382–4.

    CAS  PubMed  Google Scholar 

  397. Dithmar S, Holz FG, Voelcker H-E. Massive retinal gliose der Netzhaut. Klin Mbl Augenheilkunde. 1997;211:338–41.

    CAS  Google Scholar 

  398. Campochiaro PA, Gonzales-Fernandez F, Newman SA, Conway BP, Feldman PS. Ciliary body adenoma in a 10 year old girl who had a rhabdomyosarcoma. Arch Ophthalmol. 1992;110:681–3.

    CAS  PubMed  Google Scholar 

  399. Grossniklaus HE, Thomas JW, Vigneswaran N, Jarrett II WH. Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology. 1992;99:140–5.

    CAS  PubMed  Google Scholar 

  400. Jumper JM, Char DH, Howes Jr EL, Bitner DG. Neglected malignant medulloepithelioma of the eye. Orbit. 1999;18:1–7.

    Google Scholar 

  401. Sehu KW, Lee WR, editors. Ophthalmic pathology: an illustrated guide for clinicians. Malden: Blackwell Publishing Ltd; 2008. ISBN 9780727917799.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Southern General Hospital, Glasgow, UK

    Fiona Roberts

  2. Western General Hospital, Edinburgh, UK

    Chee Koon Thum

Authors
  1. Fiona Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chee Koon Thum
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Roberts, F., Thum, C.K. (2014). Intraocular Tumours. In: Lee's Ophthalmic Histopathology. Springer, London. https://doi.org/10.1007/978-1-4471-2476-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2476-4_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2475-7

  • Online ISBN: 978-1-4471-2476-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation